FDA Inspection 1024263 — Armando Santoro, MD
The FDA completed an inspection of Armando Santoro, MD on August 4, 2017 in Rozzano. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rozzano (Italy)
Additional Details
Clinical Investigator (CI)